# 0378-6859-77 · Lisdexamfetamine Dimesylate Capsule · Mylan Pharmaceuticals Inc., a Viatris Company — FDA drug shortage duration tracker For 0378-6859-77 · Lisdexamfetamine Dimesylate Capsule · Mylan Pharmaceuticals Inc., a Viatris Company, package ndc is 0378-6859-77; generic name is Lisdexamfetamine Dimesylate Capsule; manufacturer is Mylan Pharmaceuticals Inc., a Viatris Company; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-08. - **Package NDC:** 0378-6859-77 _(verified: appears in the quote below)_ - **Generic name:** Lisdexamfetamine Dimesylate Capsule _(verified: appears in the quote below)_ - **Manufacturer:** Mylan Pharmaceuticals Inc., a Viatris Company _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Available _(verified: appears in the quote below)_ - **Initial posting date:** 07/14/2023 _(verified: appears in the quote below)_ - **Last update date:** 08/20/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 1145 _(our reading, not quoted from the source)_ - **Dosage form:** Capsule _(verified: appears in its own passage below)_ - **Therapeutic category:** Psychiatry _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "07/14/2023", "package_ndc": "0378-6859-77", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-796-9526", "availability": "Available" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "status": "Current" ### Status > "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "status": "Current" ### Last update date > "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "status": "Current" ### Dosage form > "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "status": "Current" ### Therapeutic category > "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-08. Review by: 2026-09-11. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).